authors | McTigue, M., Deng, Y., Liu, W., Brooun, A., Stewart, A. |
Primary reference | PF-06463922 is a potent and selective next-generation ROS1/ALK inhibitor capable of blocking crizotinib-resistant ROS1 mutations., Zou HY, Li Q, Engstrom LD, West M, Appleman V, Wong KA, McTigue M, Deng YL, Liu W, Brooun A, Timofeevski S, McDonnell SR, Jiang P, Falk MD, Lappin PB, Affolter T, Nichols T, Hu W, Lam J, Johnson TW, Smeal T, Charest A, Fantin VR, Proc Natl Acad Sci U S A. 2015 Mar 2. pii: 201420785. PMID:25733882 |